Tempus
Tempus AI is a leading health technology company headquartered in Chicago, Illinois. Specializing in artificial intelligence and precision medicine, Tempus aims to revolutionize patient care by leveraging data and AI to develop personalized treatment plans across various medical fields, including oncology, cardiology, radiology, and depression. The company's comprehensive platform integrates genomic sequencing, clinical data, and AI-driven analytics to provide actionable insights for healthcare providers and researchers. We deliver a comprehensive view of your patients through our tissue and liquid tests, DNA and RNA sequencing, somatic and germline tests, tumor-normal matched profiling, and MRD and monitoring test options. We offer a fast, reliable platform for ordering Tempus tests, accessing patient insights, and utilizing our AI-driven technologies seamlessly. The first generative AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.
Learn more
MedGemma
MedGemma is a collection of Gemma 3 variants that are trained for performance on medical text and image comprehension. Developers can use MedGemma to accelerate building healthcare-based AI applications. MedGemma currently comes in two variants: a 4B multimodal version and a 27B text-only version. MedGemma 4B utilizes a SigLIP image encoder that has been specifically pre-trained on a variety of de-identified medical data, including chest X-rays, dermatology images, ophthalmology images, and histopathology slides. Its LLM component is trained on a diverse set of medical data, including radiology images, histopathology patches, ophthalmology images, and dermatology images. MedGemma 4B is available in both pre-trained (suffix: -pt) and instruction-tuned (suffix -it) versions. The instruction-tuned version is a better starting point for most applications.
Learn more
Mend
Mend is an enterprise-grade patient engagement and telehealth platform designed to help healthcare organizations profitably scale their practice and care for more patients. Founded in 2014, Mend is on a mission to revolutionize healthcare delivery so that every patient can receive extraordinary care. Mend makes it easy for healthcare providers to securely and efficiently communicate with their patients and colleagues, without concerns of violating HIPAA compliance or misplacing patient information. Mend provides integrated in-office and virtual care experiences for over 100 specialties with more than 5 million patients.
Mend's comprehensive platform works hand-in-hand with all major EHR and PMS software to facilitate more than 400,000 telehealth visits per month, increase patient satisfaction by up to 23%, reduce no-show rates as low as 4%, radically improve staff productivity, and help providers drive more revenue through better patient attendance.
Learn more
Cleerly
Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. We design intelligent clinical technologies to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis, plaque build-up in the heart's arteries, not indirect markers such as risk factors and symptoms of the disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease diagnostics and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes. Cleerly empowers providers to go beyond traditional measures of heart disease by analyzing, characterizing, and quantifying types of plaque, so they can more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health.
Learn more
